Showing results (471-480 of 794) with videos related to
Sort By:
Pageof 80
Genes, Chromosomes & Cancer|June 14, 2021
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphomaJoanna C Dalland, James B Smadbeck, Neeraj Sharma, et al.Medical Physics|August 19, 2022
Deep learning-based virtual noncalcium imaging in multiple myeloma using dual-energy CTHao Gong, Francis I Baffour, Katrina N Glazebrook, et al.European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.Mayo Clinic Proceedings|June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general populationAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.Blood|August 21, 2004
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myelomaNoopur Raje, Shaji Kumar, Teru Hideshima, et al.American Journal of Hematology|November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survivalMartha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.Blood|January 31, 2009
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyOla Landgren, Robert A Kyle, Ruth M Pfeiffer, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 13, 2023
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA studyShaji Kumar, Angela Dispenzieri, Divaya Bhutani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomesGiovanni Palladini, Angela Dispenzieri, Morie A Gertz, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2011
Clinical features of patients with immunoglobulin light chain amyloidosis (AL) with vascular-limited deposition in the kidneyAlfonso Eirin, Maria V Irazabal, Morie A Gertz, et al.Pageof 80